Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.30
10.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab - Quaterly Results
>>
USFDA completes pre-approval inspection at biologics manufacturing facility of Dr. Reddy's
>>
Dr. Reddy's Laboratories surges as its arm incorporates wholly-owned subsidiary in Jamaica
>>
Dr. Reddy's Laboratories’ arm incorporates wholly-owned subsidiary in Jamaica
>>
Dr. Reddy's Laboratories gets nod to incorporate Wholly-owned Subsidiary
>>
Dr. Reddy’s Laboratories informs about information on newspaper publication
>>
Dr. Reddy's Laboratories gains on launching Saxagliptin and Metformin Hydrochloride Extended-Release Tablets
>>
Dr. Reddy's Laboratories launches Saxagliptin and Metformin Hydrochloride Extended-Release Tablets
>>
Dr. Reddy's Laboratories gains on reporting 18% rise in Q1 consolidated net profit
<<
<
20
21
22
...143
>
>>